baber/WOPTO huggingface dataset:
Patent NZ-237230-A (NZ)
Title: Wraparound carton for bottles has tucked in upper panel to fix end closures in position
Inventor: BAKX MARTINUS C M
IPC: B65D75/08
Filed: 1991-02-26
Abstract: A carton of the wraparound type comprises top (18) and bottom panels (12, 24) connected together by spaced side wall panels (14,16:20,22) forming a tubular structure has a set of end panels (S1,S2) at each end of the tubular structure at least partially to close the ends of the carton. Each set comprises a pair of lower end closure panels (38,52) hinged to respective ones of the side wall panels which are folded towards one another to close a lower part of the end and an upper end panel (66) hinged to the top panel of the carton. The upper end panel and each of the lower end closure panels are connected by a retaining panel (70,72) which extends sufficiently internally of the tubular structure to permit it to be tucked between upper portions of the endmost articles and the respective side wall panels adjacent thereto so as to maintain the upper end panel and the lower end closure panels in position. <IMAGE>
Patent NZ-237911-A (NZ)
Title: Can carrier with apertures and tabs with multiple slits
Inventor: MARCO LESLIE STEPHEN
IPC: B65D67/02
Filed: 1991-04-22
Abstract: Carrier stock (10) is formed from a single sheet of resilient polymeric material, such as low density polyethylene, for machine application to substantially identical containers (12). The stock (10) is severable to form individual carriers (20) with container-receiving apertures (14), as defined by band segments, which include outer segments (22) formed with tear-open tabs (30). Each tab (30) and preferably the outer segment (22) have multiple slits (32,40,50,52), which are arranged to define tearable bridges (42,54,56,58) that can be easily torn by a user pulling on such tab (30), whereby the outer segment formed with such a tab (30) can be easily severed to release a container from the aperture (14) bounded partly by such a segment (22). <IMAGE>
Patent NZ-240235-A (NZ)
Title: One-component moisture-curable silicone-containing compositions comprising hydroxy-terminated polydimethylsilane
Inventor: MEURER WILLI
IPC: C08K5/57
Filed: 1991-10-15
Abstract: This invention relates to one-component silicone systems (herein referred to as 1-C-RTV compounds) which cure rapidly under the effect of moisture with elimination of certain carbonamides, develop good adhesion to many substrates in the process and give vulcanizates that are stable under extreme climatic conditions.
Patent NZ-243076-A (NZ)
Title: Water turbine mounted in water supply pipe: turbine forms rotor of generator
Inventor: FISCHER GERHARD
IPC: F03B3/04
Filed: 1992-06-09
Abstract: The plumbing fixture, which can be actuated without physical contact, has a water line that is connected to a source of water and has a water outlet. A shut-off valve is disposed in the water line downstream of a mixer valve. A control unit controls the shut-off valve as a function of control signals from a proximity-sensitive sensor. A turbine is disposed in the water line for supplying electrical energy to the control unit. Permanent magnets are distributed equidistantly about an outer periphery of a wheel of the turbine. At the level of the permanent magnets, at least two magnet coils are provided in a tubular section of the water line. The coils cooperate with the permanent magnets to form a generator.
Patent NZ-243991-A (NZ)
Title: Cyclic alkyleneimino derivatives, preparation and pharmaceutical compositions thereof
Inventor: AUSTEL VOLKHARD
IPC: C07D207/26
Filed: 1992-08-18
Abstract: The invention relates to cyclic imino derivatives of the general formula B-X5-X4-X3-X2-X1-A-Y-E (I> in which A, B, E, X2 to X5 and Y are as defined in Claim 1, their stereoisomers, their tautomers, their mixtures and their salts, especially their physiologically tolerated salts with inorganic or organic acids or bases, which have valuable pharmacological properties, preferably aggregation-inhibiting effects, to pharmaceutical compositions containing these compounds, and to process for their preparation.
Patent NZ-270035-A (NZ)
Title: Food packaging tube formed from folded web
Inventor: MELI VINCENT A
IPC: B65B9/067
Filed: 1992-05-11
Abstract: An apparatus and method are provided for forming a hermetically sealed package for a slice of a food item. A web of thermoplastic material is first formed into a tubular arrangement with a hermetic longitudinal seal. To form the tubular arrangement, means are provided for folding a continuous web of thermoplastic material into V-folded condition and for continuously forming a hermetic seal along the open longitudinal edge of the V-folded web. The hermetic seal is formed between the inner surfaces of the front and rear faces of the web to define a tubular web member. The food item which has been formed into a soft mass, is then inserted into the tubular member and the tubular member is flattened to form a thin film tube. Means are provided for forming a hermetically sealed cross-seal which are disposed substantially transverse to the longitudinal forward moving direction of the web.
Patent NZ-330747-A (NZ)
Title: Brad comprising a shank having a point at one end thereof, the tip or edge of the point being asymmetrically offset with respect to the longitudinal axis of the shank
Inventor: SUTT EDWARD G JR
IPC: F16B15/08
Filed: 1998-06-19
Abstract: brad 30, useable in a fastener driving tool, comprises a shank 60 having a longitudinal axis and a head 70 at a first end thereof, and a point 80 disposed at a second end of the shank which is opposite the first end of the shank.  Point 80 is defined by converging first 92, second 93 and third 94 surfaces.  At least one of the first and second surfaces 92, 93 of the shank is angled from a corresponding one of substantially opposite first and second sides 62, 63 of the shank so as to form an edge 96 which is disposed at an acute angle relative to the longitudinal axis of the shank.  The third surface 94 of the shank is formed by a third side of the shank and the tip 90 of the point 80 is asymmetrically offset with respect to the longitudinal axis of the shank.
Patent NZ-331215-A (NZ)
Title: Charge allocation in a multi-user network
Inventor: LYNCH-AIRD NICOLAS JAMES
IPC: H04M15/00
Filed: 1997-03-26
Abstract: his communication network includes a communication monitoring point arranged to monitor user identifiers in source/destination identifier fields to determine the charging scheme.
Patent NZ-332720-A (NZ)
Title: Therapeutic uses of bactericidal/permeability increasing (BPI) protein to treat human meningococcemia
Inventor: GIROIR BRETT P
IPC: A61P31/00
Filed: 1997-05-09
Abstract: The specification describes Methods and materials for the treatment of human meningococcemia using therapeutically effective amounts of BPI protein products.
Patent NZ-338097-A (NZ)
Title: Digitally controlled envelope elimination and restoration phase lock loop radio frequency amplifier
Inventor: MANN STEPHEN IAN
IPC: H03L7/089
Filed: 1999-09-29
Abstract: An envelope elimination and restoration amplifier for a radio transmitter includes a digital processor 20 that determines envelope E and phase P information from the RF signal B to be transmitted.  A phase locked loop 22 that is controlled by the processor generates a constant amplitude output signal having a phase modulation determined by the phase information, the output signal from the phase locked loop being amplified by the power amplifier 21 to provide the output signal S to the antenna.  The amplitude modulation (power output) of the amplifier is modulated in accordance with the derived envelope information E.
Patent NZ-503263-A (NZ)
Title: Hepatitis C NS3 protease inhibitor peptides and peptide analogues
Inventor: LLINAS-BRUNET MONTSE
IPC: C07K14/18
Filed: 1998-08-10
Abstract: Compounds, compositions, and methods for the treatment of hepatitis C virus (HCV) infection.  In particular, peptides of formula (I) that are potentially inhibitory to the NS3 protease.
Patent NZ-505342-A (NZ)
Title: Method and apparatus for collecting and preserving human saliva for drug and alcohol testing
Inventor: SCHNEIDER DAVID R
IPC: C12Q1/24
Filed: 1998-11-24
Abstract: A method and apparatus for the preservation of a saliva sample for use in subsequent quantitative chemical assays.  The method involves collecting a saliva sample at a location, directly into a specimen cup containing a predetermined volume of aqueous solution of pH buffered saline and enzymatic inhibitor and is optionally adapted with a constituent compound specific, qualitative test unit.
Patent NZ-505445-A (NZ)
Title: a circulator and components thereof
Inventor: THERKLESON GERALD LEIGH
IPC: H01P1/383
Filed: 1997-04-02
Abstract: The circulator has lens 44 for shaping a biasing magnetic field distribution to compensate for non-uniformity of magnetic field strength caused by irregularities of a magnetic circuit or the shape of a magnet 45 or ferrite 40,41.
Patent NZ-506498-A (NZ)
Title: Method for preparing cheese using the step of reverse osmosis or nanofiltration in combination with ultrafiltration
Inventor: VAN DEN BERG GERARD
IPC: A23C19/05
Filed: 1999-01-18
Abstract: A method for preparing cheese, comprising the steps of: (a) Concentrating milk by means of reverse osmosis or nanofiltration in combination with ultrafiltration and optionally diafiltration and/or microfiltration to form a concentrated milk having a content of casein which is 2-4 times higher than said content of the milk; (b) Adding rennet to the concentrated milk and accomplishing a first phase of a coagulating process at a temperature below 20oC in which K casein is split and a precoagulated milk is obtained (c) Carrying out a second phase of a coagulating process in which the precoagulated milk is heated to obtain a curd; (d) Draining the curd; and (e) Forming the cheese.
Patent NZ-509312-A (NZ)
Title: Use of oils having a high lauric acid content as an animal feed
Inventor: TETER BEVERLY B
IPC: A23K1/18
Filed: 1999-06-22
Abstract: A method for promoting animal health comprising providing an animal feed to an animal. The animal feed comprises an anti-bacterial fatty acid component, where the anti-bacterial fatty acid component is a high lauric acid natural oil, or a derivative thereof having at least 20% lauric acid as acylated fatty acids in the triglycerides, and where the content of antibiotic supplement in the animal feed is reduced or eliminated. Also described is an animal feed composition comprising crude protein and an anti- bacterial fatty acid component, where the anti-bacterial fatty acid component is a high lauric acid natural oil, or a derivative thereof having at least 20% lauric acid as acylated fatty acids in the triglycerides. Also described is a method for reducing the amount of antibiotic supplement within an animal feed comprising replacing all or a portion of the antibiotic supplement in the animal feed with an anti- bacterial fatty acid component to obtain a modified feed, where the anti-bacterial fatty acid component is a high lauric acid natural oil, or a derivative thereof having at least 20% lauric acid as acylated fatty acids in the triglycerides, where the antibiotic effect of the animal feed in enhancing feed efficiency is maintained in the modified feed. Also described is an animal feed composition comprising an anti-bacterial fatty acid component and an antibiotic supplement, where the anti-bacterial fatty acid component is coconut oil, palm kernel oil, or a high lauric acid rapeseed oil, or a derivative thereof, and the amount of antibiotic supplement in the animal feed comprises less than 50% of the maximum allowable antibiotic supplement for controlling Salmonella typhimurium.
Patent NZ-511832-A (NZ)
Title: Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester
Inventor: LEKARE GUNILLA
IPC: A61K47/44
Filed: 1999-11-12
Abstract: A  topical  composition comprising an antiinflammatory glucocorticoid and a nucleoside analogue antiviral agent  in a  pharmaceutical carrier characterized in that the  carrier comprises  about  15 to about 25 weight %  propylene  glycol and  about  10 to about 25 weight percent isopropyl  C12-C22 alkanoic  ester.  The  compositions  have  utility  in   the treatment  or  prophylaxis  of  herpesvirus  infections  and exhibit superior antiviral and therapeutic efficacy  and  an improved shelf life. The  use  of  a  composition as defined in claim  1  in  the manufacture   of   a   medicament  for  the   treatment   or prophylaxis of herpesvirus infections
Patent NZ-513614-A (NZ)
Title: Dispensing razor blade cartridges used with a handle
Inventor: METCALF STEPHEN C
IPC: A45D27/22
Filed: 1998-02-18
Abstract: A method for connecting a razor handle to razor blade cartridges held in a dispenser that includes latches that retain cartridges in predetermined positions permitting connection to a handle connecting structure on a handle as the handle is moved toward the cartridge, each latch having a latch camming structure that is shaped and positioned to interact with corresponding handle camming structure so as to cause the latch to be deflected and to unlatch a cartridge as the handle is moved toward and connected to cartridge connecting structure of a cartridge
Patent NZ-514202-A (NZ)
Title: Receptor assay
Inventor: MILLIGAN GRAEME
IPC: C07K19/00
Filed: 2000-02-18
Abstract: Receptor/reporter fusion protein based assays for detecting an effect test compounds have on a particular membrane receptor, wherein the receptor is a constitutively active mutant membrane receptor, said assay comprising the steps of: (a) adding the test compound to a cell expressing the fusion protein; and (b) detecting any change in the activity or level of the fusion protein, said change being due to the binding of a compound which affects stability of the constitutively active mutant receptor protein, thus altering the activity or level of the reporter protein in the cell.
Patent NZ-514388-A (NZ)
Title: Slag prevention steel pour dart
Inventor: PURCHASE WYNNE
IPC: C21C5/46
Filed: 2001-02-08
Abstract: A layer or sleeve 4 or 6 of carbonaceous material such as paper, or reactive metal such as aluminium or magnesium, or some combination of these materials, is provided on the lower part 3 of stem 1 or upper or lower face of the dart head 5 of a tap hole dart 2 for a steel furnace.  As steel is poured through the tap hole of the furnace the dart floats, with the stem in the tap hole, at the interface of the molten steel and the overlying slag in the furnace and gaseous material vapourizing from the paper or light metal layer on the dart at the molten steel temperature serves to force the slag away from the vortex of steel flowing through the tap hole so that slag is prevented from entering into the tap hole and casting.
Patent NZ-514668-A (NZ)
Title: Grb14 and the insulin receptor and also screening for novel medicinal products
Inventor: BURNOL ANNE-FRANCOISE
IPC: C12N9/99
Filed: 2000-03-14
Abstract: The use of Grb14 and homologous adapting proteins, as tool for screening molecules designed for the treatment of diseases involving insulin. Also described is a method for detecting molecules capable of modulating the tyrosine kinase activity of the insulin receptor.
Patent NZ-515166-A (NZ)
Title: Thiazolidinedione derivative and its use as antidiabetic
Inventor: BLACKLER PAUL DAVID JAMES
IPC: A61K31/00
Filed: 2000-04-19
Abstract: 5-[4-[2-(N-methyl-N-(2- pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione, hydrochloride dihydrate characterised in that it: (i) provides an infrared spectrum containing peaks at 3392, 2739, 1751, 1325 and 713 cm-1; and/or (ii) provides an X- ray powder diffraction (XRPD) pattern containing peaks at 9.1, 12.0, 15.7, 16.3 and 19.8 °2è; a process for preparing such a compound, a pharmaceutical composition containing such a compound and the use of such a compound in medicine.
Patent NZ-517557-A (NZ)
Title: E. coli host cells that synthesize methylmalonyl CoA
Inventor: KHOSLA CHAITAN
IPC: C12P19/44
Filed: 2000-10-13
Abstract: The use of enzymes which catalyze the production of starter and extender units for polyketides is described. These enzymes may be used to enhance the yield of polyketides that are natively produced or polyketides that are rationally designed. By using these techniques, the synthesis of a complete polyketide has been achieved in E. coli. This achievement permits a host organism with desirable characteristics to be used in the production of such polyketides and to assess the results of gene shuffling. Particularly disclosed is a recombinant E. coli host cell that incorporates: i) a propionyl CoA Carboxylase ( pcc ) expression system comprising the pccB and accA2 genes from S. coelicolor wherein said pcc expression system produces an enzyme capable of synthesizing 2S-methylmalonyl CoA ; ii) at least one expression system for a modular polyketide synthase ( PKS ); and iii) at least one expression system for a phosphopantetheniyl transferase that phosophanthetheinylates the PKS . and uses thereof.
Patent NZ-518077-A (NZ)
Title: Biologically active fragments, analogues and derivatives of VEGF-2 for the treatment of peripheral artery diseases such as critical limb ischemia and coronary disease
Inventor: COLEMAN TIMOTHY A
IPC: A61P31/12
Filed: 2001-08-03
Abstract: Combinations of cardiovascular therapeutic compounds are provided for the prophylaxis or treatment of cardiovascular disease including hypercholesterolemia, atherosclerosis, or hyperlipidemia. The combinations disclosed include an ileal bile acid transport inhibitor combined with a fibric acid derivative.
Patent NZ-520121-A (NZ)
Title: Novel substituted benzimidazole dosage forms and method of using same
Inventor: PHILLIPS JEFFREY O
IPC: A61K33/00
Filed: 2001-01-10
Abstract: A solid pharmaceutical composition comprising: (i) a proton pump inhibitor, at least a portion of which is not enteric coated; and (ii) at least one buffering agent; wherein the composition is a solid dosage unit, is disclosed. The proton pump inhibitor may be selected from omeprazole, lansoprazole, pantoprazole, rabeprazole, perprazole (S-omeprazole), pariprazole, dontoprazole, haberprazole, ransoprazole or leminoprazole. The composition disclosed is directly absorbed through the patient's stomach, upon oral administration, to provide immediate effective treatment of a gastric related disorder, wherein the gastric acid related disorder may be duodenal ulcer disease, gastric ulcer disease, gastroesophageal reflux disease, erosive esophagitis, poorly hypersecretory disease, Zollinger Ellison Syndrome, or acid dyspepsia.
Patent NZ-520749-A (NZ)
Title: Pharmaceutical composition comprising a drug, a membrane-compatible permeation enhancer and a polymeric film-forming agent
Inventor: GYURIK ROBERT J
IPC: A61K9/70
Filed: 2001-02-16
Abstract: A composition in the form of a lacquer comprising an anti-fungal agent, a membrane-permeation enhancer, and a polymeric film-forming agent is disclosed. Disclosed herein as an example is a hydrocarbon-based liquid nail lacquer comprising a solution of an anti-fungal agent in a pharmaceutically-effective amount, a membrane-compatible permeation enhancer in an amount effective to enhance penetration through a membrane or nail of said anti-fungal agent, a polymeric film-forming agent in an amount effective to form an adherent polymeric film on a membrane or nail, and a solvent for forming said solution; and a method for forming on a membrane or nail of the body an adherent film containing a pharmaceutical compound and permeation enhancer from a solution of the components in which there is used a mixture of solvents, including a solvent which is highly volatile and a solvent of lower volatility.
Patent NZ-521016-A (NZ)
Title: Alpha(s1) casein derived peptides from the N terminus portion and uses thereof in pharmaceutical compositions
Inventor: SIDELMAN ZVI
IPC: A61K38/08
Filed: 2001-03-01
Abstract: Pharmaceutical compositions comprising peptides derived from an N-terminus portion of an alpha-S1 casein are useful for the preventing or treating an autoimmune disease, viral disease, viral infection, thrombocytopenia, pancytopenia, granulocyopenia, hyperlipidemia, cholesteremia, glucosuria, diabetes, AIDS, HIV, inducing hematopoiesis, erythropoiesis, megakaryocytopoiesis, leukocytopoiesis, or thrombocytopoiesis, and inducing hematopoietic stem cell proliferation and differentiation. Also described are methods of preparing blood stem cells for implantation in a myeloablated recipient comprising treating the blood stem with a N-terminus derived alpha S1 casein peptide, prior to implantation. Preferably the peptide has the sequence set forth in SEQ ID NOs: 2-5, 8-10, 12, 14, 18, 18.
Patent NZ-521028-A (NZ)
Title: Carboxylic acid derivatives as IP antagonists
Inventor: COURNOYER RICHARD LEO
IPC: A61K31/443
Filed: 2001-03-08
Abstract: A compound comprising general formula I where: R1, R2 and R3 are independently from each other unsubstituted aryl or unsubstituted heteroaryl or aryl or heteroaryl substituted with one or more substituents selected from the group consisting of (C1-C6)-alkyl, halo, haloalkyl, trifluoromethyl, hydroxyl, hydroxyalkyl, (C1-C6)-alkoxy, (C1-C6)-alkoxycarbonyl, (C1-C6)-alkylene-dioxy forming a ring with 2 adjacent carbon atoms of the aryl ring, cyano, nitro, amino, mono- or di-((C1-C6)-alkyl)amino, (C1-C6)-alkyl- aminocarbonyl, aryl-aminocarbonyl, (C1-C6)-alkyl-carbonyl-amino, aryl, (C1-C6)-alkyl-thio, (C1-C6)-alkyl-sulfonyl, aryl- sulfonyl-amino, (C1-C6)-alkyl-aminosulfonyl or aryl-aminosulfonyl; R4 is -COOH or tetrazolyl; A is independently in each occurrence a single bond, -O(CH2)p, -S(CH2)p-, -(CH2)pO-, -(CH2)pO(CH2)p-, -(CH2)nCO(CH2)n-, -CONH-, -(CH2)p-, -HC=CH-, or -C=C-; R' is hydrogen or (C1-C6)-alkyl; B is independently in each occurrence -(CH2)q, -CH2O-, -CH2OCH2- or -CH2NH-; m, p and q are each independently in each occurrence 1, 2, or 3 n and r are each independently 0, 1, 2 or 3. The above disclosure is provided that 3-benzyloxy-2-(biphenyl-4-yl methoxycabonylamino)-propionic acid is excluded. A process for the production of a compound of formula I is also described. A pharmaceutical composition containing a compound of formula I for alleviating a disease state by treatment with an IP receptor antagonist.
Patent NZ-523318-A (NZ)
Title: A reduced protein reconstituted tobacco and method of making same
Inventor: MUA JEAN-PAUL
IPC: A24B15/24
Filed: 2001-06-21
Abstract: A method for making a tobacco material with reduced levels of nitrogenous compounds comprises: a) providing a tobacco material; b) contacting the tobacco material with a first aqueous solvent to provide an aqueous tobacco extract and a tobacco fibre portion; c) separating the aqueous tobacco extract from the tobacco fibre portion; d) contacting at a temperature of 50oC to 150oC the tobacco fibre portion with a solution containing two or more compounds selected from the group consisting of sodium acetate, sodium hydroxide and potassium hydroxide wherein the solution contains each of the compounds in a concentration of about 0.10% to 10% (w/v) of the compounds; and e) separating the solution front eh tobacco fibre portion.
Patent NZ-523706-A (NZ)
Title: Insect control pouch
Inventor: FLASHINSKI STANLEY J
IPC: A01N53/02
Filed: 2001-03-09
Abstract: An article (such as an insect control pouch) to dispense a volatile active (such as an insect control agent). The pouch is formed from a single layer polymeric non-absorbing film. The pouch traps the active until use of the pouch is desired. When the pouch is opened the walls of the pouch serve as a substrate from which the active can readily passively evaporate. Methods of forming such pouches using heat sealing techniques, and methods of using such pouches, are also disclosed